Functions of neuronal adenosine receptors
- PMID: 11111831
- DOI: 10.1007/s002100000314
Functions of neuronal adenosine receptors
Abstract
Endogenous adenosine in nervous tissue, a central link between energy metabolism and neuronal activity, varies according to behavioral state and (patho)physiological conditions, it may be the major sleep propensity substance. The functional consequences of activation of the four known adenosine receptors, A1, A2A, A2B and A3, are considered here. The mechanisms and electrophysiological actions, mainly those of the A1-receptor, have been extensively studied using in vitro brain-slice preparations. A1-receptor activation inhibits many neurons postsynaptically by inducing or modulating ionic currents and presynaptically by reducing transmitter release. A1-receptors are almost ubiquitous in the brain and affect various K+ (Ileak, IAHP), mixed cationic (Ih), or Ca2+ currents, through activation of Gi/o-proteins (coupled to ion channels, adenylyl cyclase or phospholipases). A2A-receptors are much more localized, their functional role in the striatum is only just emerging. A2B- and A3-receptors may be affected in pathophysiological events, their function is not yet clear. The cAMP-PKA signal cascade plays a central role in the regulation of both neural activity and energy metabolism. Under conditions of increased demand and decreased availability of energy (such as hypoxia, hypoglycemia and/or excessive neuronal activity), adenosine provides a powerful protective feedback mechanism. Interaction with adenosine metabolism is a promising target for therapeutic intervention in neurological and psychiatric diseases such as epilepsy, sleep, movement (parkinsonism or Huntington's disease) or psychiatric disorders (Alzheimer's disease, depression, schizophrenia or addiction).
Similar articles
-
GABAB and adenosine receptors mediate enhancement of the K+ current, IAHP, by reducing adenylyl cyclase activity in rat CA3 hippocampal neurons.J Neurophysiol. 1994 Nov;72(5):2360-7. doi: 10.1152/jn.1994.72.5.2360. J Neurophysiol. 1994. PMID: 7884464
-
Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.Ann N Y Acad Sci. 1999;890:79-92. doi: 10.1111/j.1749-6632.1999.tb07983.x. Ann N Y Acad Sci. 1999. PMID: 10668415
-
Altered regulation of potassium and calcium channels by GABA(B) and adenosine receptors in hippocampal neurons from mice lacking Galpha(o).J Neurophysiol. 2000 Feb;83(2):1010-8. doi: 10.1152/jn.2000.83.2.1010. J Neurophysiol. 2000. PMID: 10669512
-
Adaptations in adenosine signaling in drug dependence: therapeutic implications.Crit Rev Neurobiol. 2003;15(3-4):235-74. doi: 10.1615/critrevneurobiol.v15.i34.30. Crit Rev Neurobiol. 2003. PMID: 15248812 Review.
-
Purinergic inhibition of neurotransmitter release in the central nervous system.Pharmacol Toxicol. 1995 Nov;77(5):299-305. doi: 10.1111/j.1600-0773.1995.tb01031.x. Pharmacol Toxicol. 1995. PMID: 8778740 Review.
Cited by
-
Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.Psychopharmacology (Berl). 2006 Apr;185(2):160-8. doi: 10.1007/s00213-005-0284-0. Epub 2006 Feb 10. Psychopharmacology (Berl). 2006. PMID: 16470403
-
Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1061-70. doi: 10.1007/s00259-006-0309-x. Epub 2007 Jan 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17242921
-
Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1499-506. doi: 10.1007/s00259-008-0753-x. Epub 2008 Mar 29. Eur J Nucl Med Mol Imaging. 2008. PMID: 18373090
-
3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.Int J Neuropsychopharmacol. 2016 Apr 20;19(4):pyv112. doi: 10.1093/ijnp/pyv112. Print 2016 Apr. Int J Neuropsychopharmacol. 2016. PMID: 26443809 Free PMC article.
-
Ethanol-Induced Cerebellar Ataxia: Cellular and Molecular Mechanisms.Cerebellum. 2015 Aug;14(4):447-65. doi: 10.1007/s12311-014-0638-4. Cerebellum. 2015. PMID: 25578036
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous